Artificial Cell Technologies



Artificial Cell Technologies, Inc. (ACT) is a development-stage biotechnology company developing unique synthetic vaccines. ACT engineers and produces multilayer nanofilm-based vaccines using a method known as electrostatic layer-by-layer self-assembly.

The technology developed by ACT is a new approach to vaccines, because it is uniquely capable of more fully mimicking the immunogenic properties of a pathogenic organism and at the same time influencing the molecular and biological pathways of immune response.


Headquarters: New Haven, CT


Website and contact: